MONOCLONAL ANTIBODY TO HUMAN PD-1 END DETERMINATION OF ITS SPECIFIC ACTIVITY BY FLOW CYTOMETRY
- 作者: Isaeva E.N.1, Sineva S.A.1, Pigareva N.V.1, Simbirtsev A.S.1
-
隶属关系:
- FGUP ”State Research Institute of Highly Pure Biopreparations” Federal Agency for Medicine and Biology
- 期: 卷 22, 编号 3 (2019)
- 页面: 1173-1176
- 栏目: ORIGINAL ARTICLES
- URL: https://bakhtiniada.ru/1028-7221/article/view/119498
- DOI: https://doi.org/10.31857/S102872210007249-8
- ID: 119498
如何引用文章
全文:
详细
The cell receptor PD-1 is a member of the CD28. This coinhibitory receptor is a member of subfamily “immunological checkpoints”. For this reason, testing the activities of such preparations is important for clinical medicine. In this study, a human monoclonal anti PD-1 antibody was developed and tested for functional activity by flow cytometry immunophenotyping analysis. This method was demonstrated to be eff ective for protein identifi cation and for fast screening of monoclonal antibody functional activity.
作者简介
E. Isaeva
FGUP ”State Research Institute of Highly Pure Biopreparations” Federal Agency for Medicine and Biology
编辑信件的主要联系方式.
Email: e.n.isaeva@hpb.spb.ru
candidat of biology, biologist laboratory of protein biochemistry,
St. Petersburg
俄罗斯联邦S. Sineva
FGUP ”State Research Institute of Highly Pure Biopreparations” Federal Agency for Medicine and Biology
Email: fake@neicon.ru
lead biologist, laboratory of protein biochemistry,
St. Petersburg
俄罗斯联邦N. Pigareva
FGUP ”State Research Institute of Highly Pure Biopreparations” Federal Agency for Medicine and Biology
Email: fake@neicon.ru
candidat of biology, lead biologist, laboratory of protein biochemistry,
St. Petersburg
俄罗斯联邦A. Simbirtsev
FGUP ”State Research Institute of Highly Pure Biopreparations” Federal Agency for Medicine and Biology
Email: fake@neicon.ru
MD, corresponding member of RAS, Professor, of scientific adviser,
St. Petersburg
俄罗斯联邦参考
- Freeman G. J., Long A. J., Iwai Y., Bourque K., Chernova T., Nishimura H., Fitz L. J., Malenkovich N., Okazaki T., Byrne M. C., Horton H. F., Fouser L., Carter L., Ling V., Bowman M. R., Carreno B. M., Collins M., Wood C. R., Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000, 192(7), 1027–1034.
- Bennet F., Luxenberg D., Ling V., Wang L.-M., Marcquette K., Lowe D., Khan N. M., et al. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL21, but not CD28, IL-7 and IL-15 response. J. Immunol. 2003, 170, 711–718.
- Боголюбова А. В., Ефимов Г. А., Друцкая М. С., Недоспасов С. А. Иммунотерапия опухолей, основанная на блокировке иммунологических контрольных «точек» («чекпойнтов»). Медицинская иммунология 2015, 17(5), 395–406.
- Wang Yi., Wu L., Tian Ch., Zhang Y. PD-1PD-L1 immune-checkpoint blockade in malignant lymphoma. Ann Hematol. 2018, (97), 229–237.
- Топтыгина А. П. Коингибирующие молекулы в норме и при патологии. Контрольные точки (checkpoints) иммунорегуляции. Часть 2. Участие коингибирующих молекул в развитии инфекционной и онкологической патологии. Моноклональные антитела – блокаторы контрольных точек. Российский иммунологический журнал 2018, 12(1), 3–16.
- Хайдуков С. В., Байдун Л. А., Зурочка А. В., Тотолян Арег А. Стандартизованная технология «Исследование субпопуляционного состава лимфоцитов периферической крови с применением проточных цитофлюориметров-анализаторов» (Проект). Медицинская иммунология 2012, 14(3), 255–268.
- Sim J. H., Park M. J., Park S., Lee E. S. Altered expression of costimulatory molecules in Behçet’s disease according to clinical activity. Br. J. Dermatol. 2011, 164(6), 1285–1291.
- Saunders P. A., Hendrycks V. R., Lidinsky W. A. and Woods M. L. PD-L2: PD-L1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion. European Journal of Immunology 2005, 35, 3561–3569.
- Campbell D. E., Tustin N. B., Riedel E., Tustin III R., Taylor J., Murray J., and Douglas S. D. Cryopreservation decreases receptor PD-1 co-inhibitory expression on peripheral blood mononuclear cell-derived T cells and monocytes. Clinical and Vaccine Immunology 2009, 9, 1648–1653.
补充文件
